LOC554202 was found to be overexpressed in laryngeal squamous cell carcinoma, oral cancer, and lung adenocarcinoma and downregulated in bladder carcinoma, gastric carcinoma, colorectal carcinoma, and esophageal squamous cell carcinoma [3–6]. Here, MIR31HG is linked to lip and oral cavity carcinoma.